| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.038 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |